Status:

UNKNOWN

Assessing a WeChat-based Integrative Family Intervention (WIFI) for Schizophrenia

Lead Sponsor:

Xiangya Hospital of Central South University

Conditions:

Schizophrenia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study aims to test both the effectiveness and implementation strategy of a WeChat-based integrative family intervention (WIFI) to support family caregiving of schizophrenia in China.

Detailed Description

The investigators will conduct a type 2 hybrid effectiveness-implementation study to test both the effect of and the implementation process of a WeChat-based integrative family intervention (WIFI) pro...

Eligibility Criteria

Inclusion

  • For people living with schizophrenia:
  • being registered in the "686 Program"
  • fulfilling the Chinese Classification of Mental Disorders-3 (CCMD-3) or the International Classification of Diseases-10 (ICD-10) criteria for schizophrenia
  • living with at least one family member
  • able to use a smartphone and WeChat to read and communicate
  • For family members:
  • joining the Reward Policy and receiving a subsidy for family care
  • living with schizophrenia individuals for at least the past two years
  • involved with caregiving activities of schizophrenia individuals
  • able to use a smartphone and WeChat to read and communicate
  • at least one family member having a smartphone with WeChat app installed.

Exclusion

  • For people living with schizophrenia:
  • diagnosed with mental illness other than schizophrenia
  • living alone with no family members
  • not able to use smartphones or WeChat
  • For family members:
  • not involved with caregiving activities for the schizophrenia individuals
  • not able to use smartphones or WeChat

Key Trial Info

Start Date :

September 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2022

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT04393896

Start Date

September 1 2021

End Date

June 30 2022

Last Update

April 9 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xiangya Hospital

Changsha, Hunan, China, 410008